
B. Riley Securities Keeps Their Buy Rating on InfuSystem Holdings (INFU)

B. Riley Securities analyst Anderson Schock has maintained a Buy rating on InfuSystem Holdings (INFU) with a price target of $12.00, while the stock closed at $10.00. The analyst has a strong track record, with a 37.0% average return and a 90.00% success rate. The consensus rating for InfuSystem is Strong Buy, with a price target consensus of $14.50, indicating a potential upside of 45.00%. Roth MKM also reiterated a Buy rating with a $14.00 price target.
B. Riley Securities analyst Anderson Schock maintained a Buy rating on InfuSystem Holdings yesterday and set a price target of $12.00. The company’s shares closed yesterday at $10.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Schock covers the Healthcare sector, focusing on stocks such as Exagen, InfuSystem Holdings, and Varex Imaging. According to TipRanks, Schock has an average return of 37.0% and a 90.00% success rate on recommended stocks.
InfuSystem Holdings has an analyst consensus of Strong Buy, with a price target consensus of $14.50, implying a 45.00% upside from current levels. In a report released yesterday, Roth MKM also reiterated a Buy rating on the stock with a $14.00 price target.

